FDA.reportPublic FDA data

Application 088388

Type
ANDA
Sponsor
DEPROCO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SCANDONEST LLEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDEINJECTABLE;INJECTION0.05MG/ML;2%NoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0362-0931Carbocaine with Neo-CobefrinMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-0931Carbocaine with Neo-CobefrinMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-0931Carbocaine with Neo-CobefrinMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-1097Scandonest 2% LMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-1097Scandonest 2% LMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-1097Scandonest 2% LMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
0362-1097Scandonest 2% LMepivacaine Hydrochloride and LevonordefrinSeptodont, Inc.ANDACurrent
31382-931Carbocaine with Neo-CobefrinMepivacaine hydrochloride and LevonordefrinCaresteam Health, Inc.ANDACurrent
51004-1097Scandonest LMepivacaine Hydrochloride and LevonordefrinNovocol Pharmaceutical of Canada, IncANDACurrent
66467-9790Mepivacaine Hydrochloride and LevonordefrinMepivacaine Hydrochloride and LevonordefrinDarby Dental Supply, LLCANDACurrent